• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在LNCaP细胞系中,C/EBPα对前列腺特异性抗原(PSA)的下调与雄激素受体(AR)表达缺失及PSA启动子活性受抑制有关。

Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.

作者信息

Yin Hong, Radomska Hanna S, Tenen Daniel G, Glass Jonathan

机构信息

Feist-Weiller Cancer Center and Department of Medicine, LSU Health Sciences Center, Shreveport, LA, USA.

出版信息

BMC Cancer. 2006 Jun 14;6:158. doi: 10.1186/1471-2407-6-158.

DOI:10.1186/1471-2407-6-158
PMID:16774685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1544346/
Abstract

BACKGROUND

C/EBPalpha is a transcription factor essential for terminal differentiation of several cell types. It has not known if C/EBPalpha protein is expressed and functions in the prostate gland.

METHODS

The presence of C/EBPalpha in normal and cancerous prostate epithelium was examined by immunochemistry. Over expression of C/EBPalpha in LNCaP cells was conducted with retrovirus-mediated transduction. PSA expression was examined by RT-PCR and western blot and PSA promoter activity by luciferase reporter assay.

RESULTS

In normal prostate C/EBPalpha was expressed in the basal layer of the epithelium. In prostate cancer C/EBPalpha was detected at low levels throughout the cancers and in advanced prostate cancer C/EBPalpha expression was associated with decreased expression of AR and PSA. Overexpression of C/EBPalpha inhibited epigenetically PSA expression and was accompanied by the loss of expression of AR. Transient increase of C/EBPalpha inhibited the PSA promoter/enhancer activity independently of expression of AR.

CONCLUSION

In LNCaP cells C/EBPalpha over expression inhibits expression of PSA by AR -dependent and independent mechanisms and by extinguishing AR expression provides a model for hormonal independent cell growth.

摘要

背景

C/EBPα是几种细胞类型终末分化所必需的转录因子。目前尚不清楚C/EBPα蛋白在前列腺中是否表达并发挥作用。

方法

采用免疫化学方法检测正常和癌性前列腺上皮中C/EBPα的存在情况。通过逆转录病毒介导的转导在LNCaP细胞中过表达C/EBPα。通过RT-PCR和蛋白质印迹法检测前列腺特异性抗原(PSA)的表达,并通过荧光素酶报告基因测定法检测PSA启动子活性。

结果

在正常前列腺中,C/EBPα在上皮的基底层表达。在前列腺癌中,整个癌组织中均检测到低水平的C/EBPα,在晚期前列腺癌中,C/EBPα表达与雄激素受体(AR)和PSA表达降低相关。C/EBPα的过表达通过表观遗传方式抑制PSA表达,并伴有AR表达缺失。C/EBPα的短暂增加独立于AR的表达抑制了PSA启动子/增强子活性。

结论

在LNCaP细胞中,C/EBPα的过表达通过依赖AR和不依赖AR的机制抑制PSA表达,并且通过消除AR表达为激素非依赖性细胞生长提供了一个模型。

相似文献

1
Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.在LNCaP细胞系中,C/EBPα对前列腺特异性抗原(PSA)的下调与雄激素受体(AR)表达缺失及PSA启动子活性受抑制有关。
BMC Cancer. 2006 Jun 14;6:158. doi: 10.1186/1471-2407-6-158.
2
The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.CCAAT增强子结合蛋白α负向调节前列腺癌细胞中雄激素受体的反式激活。
Mol Endocrinol. 2006 May;20(5):984-95. doi: 10.1210/me.2005-0240. Epub 2006 Feb 2.
3
Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.前列腺特异性抗原启动子增强子核心区域负调控顺式元件的鉴定:对前列腺癌细胞中雄激素受体与核因子-κB信号通路交叉的意义
Biochem J. 2004 Apr 15;379(Pt 2):421-31. doi: 10.1042/BJ20031661.
4
PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.PC-SPES:诱导LNCaP人前列腺癌细胞凋亡及下调前列腺特异性抗原(PSA)表达的分子机制
Int J Oncol. 2003 Nov;23(5):1461-70.
5
Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.C/EBPα在前列腺癌细胞中的稳定表达下调金属硫蛋白并增加锌诱导的毒性。
Prostate. 2005 Feb 15;62(3):209-16. doi: 10.1002/pros.20136.
6
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.分化剂丁酸盐在人前列腺癌细胞中对雄激素受体的非配体依赖性激活。
Cancer Res. 2000 Oct 15;60(20):5825-31.
7
Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).鞘脂激活蛋白原上调前列腺癌细胞(LNCaP)中雄激素受体(AR)和前列腺特异性抗原(PSA)的表达及活性。
Prostate. 2007 Feb 1;67(2):178-89. doi: 10.1002/pros.20513.
8
Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.吲哚 - 3 - 甲醇对人前列腺癌细胞中雄激素受体表达的抑制及雄激素反应性的下调。
Carcinogenesis. 2005 Nov;26(11):1896-904. doi: 10.1093/carcin/bgi155. Epub 2005 Jun 15.
9
FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.叉头框蛋白M1(FOXM1)通过调节前列腺特异性抗原(PSA)基因转录促进前列腺癌进展。
Oncotarget. 2017 Mar 7;8(10):17027-17037. doi: 10.18632/oncotarget.15224.
10
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells.染色质重塑因子 SRCAP 调节前列腺癌细胞中前列腺特异性抗原和细胞增殖的表达。
J Cell Physiol. 2010 Aug;224(2):369-75. doi: 10.1002/jcp.22132.

引用本文的文献

1
Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence.慢性 IL-1 暴露促使 LNCaP 细胞发生雄激素和 AR 非依赖性演变。
PLoS One. 2020 Dec 16;15(12):e0242970. doi: 10.1371/journal.pone.0242970. eCollection 2020.
2
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.C/EBPα在实体瘤中的肿瘤抑制作用:不止于脂肪和血液。
Oncogene. 2017 Sep 14;36(37):5221-5230. doi: 10.1038/onc.2017.151. Epub 2017 May 15.
3
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

本文引用的文献

1
The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.CCAAT增强子结合蛋白α负向调节前列腺癌细胞中雄激素受体的反式激活。
Mol Endocrinol. 2006 May;20(5):984-95. doi: 10.1210/me.2005-0240. Epub 2006 Feb 2.
2
Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein.去磷酸化的C/EBPα通过隔离视网膜母细胞瘤蛋白来加速细胞增殖。
Mol Cell Biol. 2005 Feb;25(4):1325-38. doi: 10.1128/MCB.25.4.1325-1338.2005.
3
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
靶向抑制BMI1可抑制CEBPα表达低的肺腺癌的肿瘤生长。
Sci Transl Med. 2016 Aug 3;8(350):350ra104. doi: 10.1126/scitranslmed.aad6066.
4
Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.靶向BikDD表达可杀死雄激素依赖性和去势抵抗性前列腺癌细胞。
Mol Cancer Ther. 2014 Jul;13(7):1813-25. doi: 10.1158/1535-7163.MCT-13-1004. Epub 2014 Apr 30.
5
The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells.在前列腺癌细胞中,nrf1 和 nrf2 的平衡在氧化应激调节和雄激素信号中起作用。
Cancers (Basel). 2010 Jun 21;2(2):1354-78. doi: 10.3390/cancers2021354.
6
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.倍半萜内酯小白菊内酯对前列腺肿瘤起始细胞的影响:一种综合分子谱分析方法。
Prostate. 2009 Jun 1;69(8):827-37. doi: 10.1002/pros.20931.
7
Dysregulation of the C/EBPalpha differentiation pathway in human cancer.人类癌症中C/EBPα分化途径的失调。
J Clin Oncol. 2009 Feb 1;27(4):619-28. doi: 10.1200/JCO.2008.17.9812. Epub 2008 Dec 15.
8
Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.由组蛋白乙酰化、共调节因子和转录能力定义的具有不同功能的基因组雄激素受体占据区域。
PLoS One. 2008;3(11):e3645. doi: 10.1371/journal.pone.0003645. Epub 2008 Nov 10.
9
Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.锌指转录因子结合位点在前列腺癌中与WT1共表达基因启动子中的进化保守性。
BMC Genomics. 2008 Jul 16;9:337. doi: 10.1186/1471-2164-9-337.
10
Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.CCAAT/增强子结合蛋白α在前列腺产后发育及恶性肿瘤中的表达与亚细胞定位
Prostate. 2008 Aug 1;68(11):1206-14. doi: 10.1002/pros.20779.
雄激素非依赖性前列腺癌是一组异质性疾病:快速尸检项目的经验教训。
Cancer Res. 2004 Dec 15;64(24):9209-16. doi: 10.1158/0008-5472.CAN-04-2442.
4
Role of p63 and basal cells in the prostate.p63和基底细胞在前列腺中的作用。
Development. 2004 Oct;131(20):4955-64. doi: 10.1242/dev.01384. Epub 2004 Sep 15.
5
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.雄激素受体(AR)在AR阴性前列腺癌细胞中的表达导致双氢睾酮(DHT)和胰岛素样生长因子-I(IGF-I)对局限性肿瘤和转移性肿瘤之间的增殖及AR活性产生不同影响。
Prostate. 2004 Nov 1;61(3):276-90. doi: 10.1002/pros.20099.
6
Prostate specific antigen gene regulation by androgen receptor.雄激素受体对前列腺特异性抗原基因的调控
J Cell Biochem. 2004 Oct 1;93(2):233-41. doi: 10.1002/jcb.20228.
7
Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.前列腺特异性抗原:对最常用癌症生物标志物验证情况的综述
Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480.
8
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.前列腺特异性抗原水平≤4.0纳克/毫升的男性中前列腺癌的患病率。
N Engl J Med. 2004 May 27;350(22):2239-46. doi: 10.1056/NEJMoa031918.
9
Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.肝肿瘤通过PI3K/Akt介导的对C/EBPα生长抑制活性的阻断,逃避增殖的负调控。
Genes Dev. 2004 Apr 15;18(8):912-25. doi: 10.1101/gad.1183304.
10
Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen.前列腺癌细胞与骨髓内皮的黏附:前列腺特异性抗原的作用。
Cancer Res. 2004 Mar 15;64(6):2083-9. doi: 10.1158/0008-5472.can-03-3487.